Energy was abundant at MD Anderson’s Children’s Cancer Hospital in January, when leaders of Energy Transfer Partners (ETP) and Sunoco LP toured Pediatrics, met staff and presented a check for $1 million.
Dallas-based ETP, a master limited partnership with one of the largest and most diversified energy portfolios in the U.S., and its employees have given $2.5 million to MD Anderson since 2014. These funds have supported key pediatric cancer research initiatives.
Peter Pisters, M.D., president of MD Anderson; Richard Gorlick, M.D., division head, Pediatrics; and Kris Mahadeo, M.D., section chief and medical director of Pediatric Stem Cell Therapy, accepted the donation.
“It is critical that we find a cure for pediatric cancer,” says Gorlick. “Cancer is the No. 1 cause of death in children due to disease, and currently only 3% of funding goes into pediatric cancer research. This donation will help fill a large gap of what’s needed to treat young patients.”
The past year was a phenomenal year for pediatric cancer immunotherapy, which uses a patient’s immune system to fight cancer, says Mahadeo.
“Among children who receive treatment for leukemia, almost 90% are cured,” he says. “We want to see that reach 100%. This donation will help us to better achieve that goal.”